Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects

NCT00700076 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ketamine and Org 25935
DRUG: Placebo and Ketamine

Sponsor

Yale University

Collaborators

[object Object]